4 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
News 2026-10-29 10:31 UTC
Adj. EPS $2.49, est. $2.07 Rev. $18.09B, est. $17.31B Keytruda rev. $8.60B, est. $8.38B Gardasil rev. $2.00B, est. $1.75B Keytruda Qlex rev. $830M, est. $699.6M Winrevair rev. $694M, est. $643.1M Animal Health sales $1.68B, est. $1.69B Sees FY sales $66.8B to $67.3B, saw $66.3B to $67.3B Sees FY Adj. EPS $2.77 to $2.82
News 2026-10-28 11:00 UTC
Merck is scheduled to report Q3'26 results on October 29 before the market opens. Revenue and EPS estimates were provided ahead of the report.
News 2026-10-28 03:07 UTC
Global pharmaceutical company Merck NYSE:MRKwill be reporting earnings this Thursday before market open. Here’s what investors should know.Merck beat analysts’ revenue expectations last quarter, reporting revenues of $16.61 billion, up 5.1% year on year. It was a satisfactory quarter for the compan…
News 2026-10-01 10:45 UTC
Merck will host its third-quarter 2026 sales and earnings conference call on Thursday, Oct. 29, at 9:00 a.m. ET.